Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
1. 系统已在2025-09-23 16:20:48对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1470-2045(25)00379-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525003791
其他信息:
出版社: Elsevier BV
作者: Cathalijne C B Post; Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Alexandra Leary; Petronella B Ottevanger; Mary McCormack; Pearly Khaw; Romerai D'Amico; Anthony Fyles; Cyrus Chargari; Henry C Kitchener; Viet Do; Andrea Lissoni; Diane Provencher; Catherine Genestie; Hans W Nijman; Karen Whitmarsh; Ina M Jürgenliemk-Schulz; Amanda Feeney; Ludy C H W Lutgens; Jeanette Bouma; Alicia Leon-Castillo; Remi A Nout; Hein Putter; Tjalling Bosse; Carien L Creutzberg
